These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 17186330)

  • 21. Oral sorbent AST-120 increases renal NO synthesis in uremic rats.
    Tumur Z; Niwa T
    J Ren Nutr; 2008 Jan; 18(1):60-4. PubMed ID: 18089446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of oral adsorbent on gene expression profile in uremic rat kidney: cDNA array analysis.
    Aoyama I; Enomoto A; Niwa T
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S8-14. PubMed ID: 12612943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral adsorbent AST-120 potentiates the effect of erythropoietin-stimulating agents on Stage 5 chronic kidney disease patients: a randomized crossover study.
    Wu IW; Hsu KH; Sun CY; Tsai CJ; Wu MS; Lee CC
    Nephrol Dial Transplant; 2014 Sep; 29(9):1719-27. PubMed ID: 24714415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolomic search for uremic toxins as indicators of the effect of an oral sorbent AST-120 by liquid chromatography/tandem mass spectrometry.
    Kikuchi K; Itoh Y; Tateoka R; Ezawa A; Murakami K; Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(29):2997-3002. PubMed ID: 20870466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New oral spherical carbon adsorbent effectively reduces serum indoxyl sulfate levels in moderate to advanced chronic kidney disease patients: a multicenter, prospective, open-label study.
    Kim SH; Jhee JH; Choi HY; Lee SH; Shin SK; Lee SY; Yang DH; Yi JH; Han SW; Jo YI; Park HC
    BMC Nephrol; 2020 Jul; 21(1):317. PubMed ID: 32736531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of carbon adsorbent in the conservative management of chronic kidney disease.
    Niwa T
    Panminerva Med; 2017 Jun; 59(2):139-148. PubMed ID: 27990791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accumulation of indoxyl sulfate in OAT1/3-positive tubular cells in kidneys of patients with chronic renal failure.
    Taki K; Nakamura S; Miglinas M; Enomoto A; Niwa T
    J Ren Nutr; 2006 Jul; 16(3):199-203. PubMed ID: 16825019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uremic toxicity of indoxyl sulfate.
    Niwa T
    Nagoya J Med Sci; 2010 Feb; 72(1-2):1-11. PubMed ID: 20229698
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indoxyl sulfate increases the gene expressions of TGF-beta 1, TIMP-1 and pro-alpha 1(I) collagen in uremic rat kidneys.
    Miyazaki T; Ise M; Seo H; Niwa T
    Kidney Int Suppl; 1997 Nov; 62():S15-22. PubMed ID: 9350672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of AST-120 in Chronic Kidney Disease Treatment: Still a Controversy?
    Yamaguchi J; Tanaka T; Inagi R
    Nephron; 2017; 135(3):201-206. PubMed ID: 27960172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AST-120 ameliorates epithelial-to-mesenchymal transition and interstitial fibrosis in the kidneys of chronic kidney disease rats.
    Bolati D; Shimizu H; Niwa T
    J Ren Nutr; 2012 Jan; 22(1):176-80. PubMed ID: 22200438
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term effects of the oral adsorbent, AST-120, in patients with chronic renal failure.
    Maeda K; Hamada C; Hayashi T; Shou I; Wakabayashi M; Fukui M; Horikoshi S; Tomino Y
    J Int Med Res; 2009; 37(1):205-13. PubMed ID: 19215692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic kidney disease-induced cardiac fibrosis is ameliorated by reducing circulating levels of a non-dialysable uremic toxin, indoxyl sulfate.
    Lekawanvijit S; Kompa AR; Manabe M; Wang BH; Langham RG; Nishijima F; Kelly DJ; Krum H
    PLoS One; 2012; 7(7):e41281. PubMed ID: 22829936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of indoxyl sulfate in the progression of chronic kidney disease and cardiovascular disease: experimental and clinical effects of oral sorbent AST-120.
    Niwa T
    Ther Apher Dial; 2011 Apr; 15(2):120-4. PubMed ID: 21426500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of oral adsorbent AST-120 concurrent with a low-protein diet on the progression of chronic renal failure.
    Owada A; Shiigai T
    Am J Nephrol; 1996; 16(2):124-7. PubMed ID: 8919228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous Reduction of Protein-Bound Uraemic Toxins with Improved Oxidative Stress by Using the Oral Charcoal Adsorbent AST-120 in Haemodialysis Patients.
    Yamamoto S; Kazama JJ; Omori K; Matsuo K; Takahashi Y; Kawamura K; Matsuto T; Watanabe H; Maruyama T; Narita I
    Sci Rep; 2015 Sep; 5():14381. PubMed ID: 26395517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spherical carbon adsorbent (AST-120) protects deterioration of renal function in chronic kidney disease rats through inhibition of reactive oxygen species production from mitochondria and reduction of serum lipid peroxidation.
    Owada S; Maeba T; Sugano Y; Hirayama A; Ueda A; Nagase S; Goto S; Nishijima F; Bannai K; Yamato H
    Nephron Exp Nephrol; 2010; 115(4):e101-11. PubMed ID: 20424488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An oral adsorbent, AST-120, combined with a low-protein diet and RAS blocker, for chronic kidney disease.
    Yorioka N; Kiribayashi K; Naito T; Ogata S; Yokoyama Y; Kyuden Y; Ogawa T; Wada K; Hayashi K; Hirabayashi A
    J Nephrol; 2008; 21(2):213-20. PubMed ID: 18446716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of oral-adsorbent (AST-120) in chronic renal failure (CRF) in rats].
    Sakai T; Kumano K; Takara S; Kuwao S; Ise M; Sugano M; Uehara Y
    Nihon Jinzo Gakkai Shi; 1989 Apr; 31(4):359-65. PubMed ID: 2747009
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma renin-angiotensin system or protein intake.
    Horike K; Usami T; Kamiya Y; Kamiya T; Yoshida A; Itoh S; Yamato H; Ise M; Kimura G
    Clin Exp Nephrol; 2003 Jun; 7(2):120-4. PubMed ID: 14586730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.